VIBRating vs Traditional Therapy for Treatment of ENTry Dyspareunia

Recruiting N/A Interventional Study
Genito-Pelvic Pain/Penetration Disorder Dyspareunia Vaginismus Pelvic Pain Vestibulodynia Vulvodynia (Chronic Vulvar Pain)
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Female
Study type
Interventional
Purpose
Treatment
Participants needed
60 (estimated)
Sponsor
Medstar Health Research Institute · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this randomized controlled trial is to determine whether the use of a novel vibrating pelvic floor therapeutic device ("Kiwi") improves sexual function in sexually active women aged 18 and older with genito-pelvic pain and penetration disorder (GPPPD) more effectively than traditional vaginal dilators. The main questions it aims to answer are: 1. Does the use of the Kiwi device lead …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Assigned female at birth * Age ≥ 18 years old * Genito-pelvic pain/penetration disorder (per ICD-10 diagnosis codes: F52.5 Vaginismus not due to a substance or known physiological condition, F52.6 Dyspareunia not due to a substance or known physiological condition, N94.1 Dyspa…
Contacts

Helen Y Zhang, MD

202-877-6526

helen.y.zhang@medstar.net

CONTACT

Eun Sook Choi, MD

202-877-6526

eunsook.choi@medstar.net

CONTACT